Published in Arch Surg on October 01, 1970
Perforation of the gastrointestinal tract secondary to ingestion of foreign bodies. World J Surg (2006) 4.71
Liver abscess secondary to a broken needle migration--a case report. BMC Surg (2003) 2.17
Bowel perforation caused by swallowed chicken bones--a case series. Ulster Med J (2007) 1.82
A case of fish bone perforation of the stomach mimicking a locally advanced pancreatic carcinoma. Dig Dis Sci (2005) 1.68
Toothpick perforation of the intestines. Ann Surg (1977) 1.67
Successful treatment of a hepatic abscess that formed secondary to fish bone penetration by percutaneous transhepatic removal of the foreign body: report of a case. Surg Today (1999) 1.54
Ruptured hepatic abscess caused by fish bone penetration of the duodenal wall: report of a case. Surg Today (2007) 1.30
Pancreatic and hepatic abscess secondary to fish bone perforation of the duodenum. Dig Dis Sci (2005) 1.26
Recurrent liver abscess secondary to ingested fish bone migration: report of a case. Surg Today (2008) 1.13
Cocktail stick injuries--the dangers of half a stick. Ulster Med J (2005) 1.11
Toothpick perforation of the inferior vena cava. West J Med (1983) 1.08
Unusual foreign bodies of the aerodigestive tract. Indian J Otolaryngol Head Neck Surg (2002) 0.99
Peritonitis with small bowel perforation caused by a fish bone in a healthy patient. World J Gastroenterol (2014) 0.98
Successful treatment of liver abscess secondary to foreign body penetration of the alimentary tract: a case report and literature review. World J Gastroenterol (2014) 0.96
Fish bone penetration of the duodenum extending into the pancreas: report of a case. Surg Today (2010) 0.94
Free perforation of the small intestine. Ann Surg (1982) 0.92
Extraction and clipping repair of a chicken bone penetrating the gastric wall. World J Gastroenterol (2008) 0.90
Medical treatment for a fish bone-induced ileal micro-perforation: a case report. World J Gastroenterol (2012) 0.84
Inflammatory pseudotumor of liver secondary to migrated fishbone - a rare cause with an unusual presentation. Ann Gastroenterol (2013) 0.83
Laparoscopic retrieval of an unusual foreign body. J Minim Access Surg (2014) 0.83
Intestinal perforation by an ingested foreign body. Radiol Bras (2016) 0.83
Endoscopic removal of a foreign body perforating the duodenum. Can Med Assoc J (1977) 0.81
Fish bone perforation of the terminal ileum presenting as acute appendicitis. BMJ Case Rep (2014) 0.81
Successful endoscopic management of fish bone embedded into the bladder wall. Case Rep Med (2010) 0.80
Small bowel perforation due to fish bone: A case report. Turk J Emerg Med (2016) 0.79
Fishbone-induced perforated appendicitis. BMJ Case Rep (2015) 0.78
Accidental Implant Screwdriver Ingestion: A Rare Complication during Implant Placement. J Dent (Tehran) (2014) 0.77
Toothpick perforation of the duodenum. West J Med (1980) 0.76
Unusual differential diagnosis of upper abdominal pain. Diagn Ther Endosc (2009) 0.76
Bronchial impaction of an implant screwdriver after accidental aspiration: report of a case and revision of the literature. Oral Maxillofac Surg (2010) 0.76
Repeated colon penetration by an ingested fish bone: report of a case. Surg Today (2008) 0.76
Laparoscopically detected and nonsurgically managed ileal perforation by an ingested fish bone: a case report. J Med Case Rep (2015) 0.75
A fish bone-related hepatic abscess. Clin Pract (2011) 0.75
Clasp knife in the gut: a case report. BMC Surg (2003) 0.75
Accidental ingestion of a cocktail stick. BMJ Case Rep (2010) 0.75
Gastric Perforation by Ingested Rabbit Bone Fragment. Case Rep Gastroenterol (2016) 0.75
Successful endoscopic management of gastric perforation caused by ingesting a sharp chicken bone. Int J Surg Case Rep (2015) 0.75
Orthodontic Wire Ingestion during Treatment: Reporting a Case and Review the Management of Foreign Body Ingestion or Aspiration (Emergencies). Case Rep Dent (2013) 0.75
Fishbone Perforated Appendicitis. J Radiol Case Rep (2016) 0.75
Intestinal perforation secondary to ingested foreign bodies: a single-center experience with 38 cases. Pediatr Surg Int (2017) 0.75
Terminal ileostomy and on-table enteroscopy-A case report describing a novel approach for retrieval of foreign bodies in the difficult abdomen. Int J Surg Case Rep (2017) 0.75
Obstruction and perforation of the small bowel caused by inadvertent ingestion of a blister pill pack in an elderly patient. BMJ Case Rep (2015) 0.75
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin Pharmacol Ther (2011) 5.44
Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med (1997) 4.13
High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet (1999) 3.63
Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. J Natl Cancer Inst (1999) 3.58
Acute lymphoblastic leukemia. N Engl J Med (1998) 3.15
Pharmacogenomics and individualized medicine: translating science into practice. Clin Pharmacol Ther (2012) 2.48
The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancer. Clin Pharmacol Ther (2013) 2.40
Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia. N Engl J Med (1997) 2.38
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia (2009) 2.24
Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood (1999) 2.18
A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical record. Clin Pharmacol Ther (2012) 2.12
Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update. Clin Pharmacol Ther (2013) 1.99
Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia (2000) 1.94
Lipoprotein analysis in the evaluation of chest pain in the emergency department. Mayo Clin Proc (1991) 1.92
Nomenclature for human CYP2D6 alleles. Pharmacogenetics (1996) 1.91
Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia. Blood (2000) 1.89
Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med (1991) 1.83
Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia. Clin Pharmacol Ther (2008) 1.82
Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. Am J Hum Genet (1996) 1.73
Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect. N Engl J Med (1986) 1.67
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia (2003) 1.64
Concordance of DMET plus genotyping results with those of orthogonal genotyping methods. Clin Pharmacol Ther (2012) 1.62
Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood (1998) 1.60
Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia. Ann Hematol (2004) 1.57
Review of small bowel obstruction at Milwaukee County General Hospital. Am J Surg (1966) 1.56
Pharmacogenomics: unlocking the human genome for better drug therapy. Annu Rev Pharmacol Toxicol (2001) 1.56
Determination of viability of ischemic intestine by Doppler ultrasound. Surgery (1978) 1.54
Bypass grafting to distal arteries for limb salvage. Surg Gynecol Obstet (1972) 1.54
Thiopurine methyltransferase activity in American white subjects and black subjects. Clin Pharmacol Ther (1994) 1.51
Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Clin Pharmacol Ther (1992) 1.51
Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms. Pharmacogenetics (1996) 1.50
Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate. J Clin Invest (1996) 1.49
Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia (2000) 1.48
Patient characteristics associated with high-risk methotrexate concentrations and toxicity. J Clin Oncol (1994) 1.48
Childhood acute lymphoblastic leukaemia--current status and future perspectives. Lancet Oncol (2001) 1.48
Cardiovascular risk factors in patients with peripheral vascular disease. Surgery (1978) 1.44
Acute suppurative cholangitis. Experience with 15 consecutive cases. Arch Surg (1967) 1.43
Mutations at codon 974 of the DPYD gene are a rare event. Br J Cancer (1997) 1.42
Risk of adverse events in children completing treatment for acute lymphoblastic leukemia: St. Jude Total Therapy studies VIII, IX, and X. J Clin Oncol (1991) 1.42
Polymorphism of the thiopurine S-methyltransferase gene in African-Americans. Hum Mol Genet (1999) 1.40
Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol (2000) 1.37
A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase. Proc Natl Acad Sci U S A (1995) 1.36
The effects of "cell age" upon the lethal effects of physical and chemical mutagens in the yeast, Saccharomyces cerevisiae. Mol Gen Genet (1976) 1.34
ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence. Leukemia (2010) 1.34
A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. Am J Hum Genet (1995) 1.33
Pharmacogenetics of cancer therapy: getting personal. Am J Hum Genet (1998) 1.31
Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient. Lancet (1993) 1.29
Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia. Blood (1994) 1.29
Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. J Clin Invest (1994) 1.29
Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia. Blood (1995) 1.29
Late effects of treatment in survivors of childhood acute myeloid leukemia. J Clin Oncol (2000) 1.28
Blind river dolphin: first side-swimming cetacean. Science (1969) 1.25
Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia. Blood (1996) 1.24
Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity. Proc Natl Acad Sci U S A (1997) 1.23
Differences in folylpolyglutamate synthetase and dihydrofolate reductase expression in human B-lineage versus T-lineage leukemic lymphoblasts: mechanisms for lineage differences in methotrexate polyglutamylation and cytotoxicity. Mol Pharmacol (1997) 1.23
Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia. Lancet (2000) 1.21
Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemia. Blood (1997) 1.18
Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies. Leukemia (1997) 1.18
Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase. Mol Pharmacol (1995) 1.15
Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity. Clin Pharmacol Ther (2010) 1.15
Seroepidemiology of Neospora caninum infection in dairy cattle herds in Mashhad area, Iran. Vet Parasitol (2005) 1.14
Nonparasitic splenic cysts. Case report of epidermoid cyst with review of the literature. Am J Surg (1973) 1.14
Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia. Leukemia (1998) 1.14
Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. J Clin Oncol (1996) 1.14
Genetic polymorphism of thiopurine S-methyltransferase: molecular mechanisms and clinical importance. Pharmacology (2000) 1.13
Pharmacokinetics of subcutaneous methotrexate. J Clin Oncol (1988) 1.11
Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase (TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT*2, TPMT*3A, TPMT*3B or TPMT*3C. Pharmacogenetics (1999) 1.11
Using HapMap tools in pharmacogenomic discovery: the thiopurine methyltransferase polymorphism. Clin Pharmacol Ther (2007) 1.11
Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia. Leukemia (2012) 1.10
ORAL PENICILLIN WITH BASIC ALUMINUM AMINOACETATE. Science (1945) 1.10
Pharmacokinetics and toxicity of methotrexate in children with Down syndrome and acute lymphocytic leukemia. J Pediatr (1987) 1.10
A novel protein complex distinct from mismatch repair binds thioguanylated DNA. Mol Pharmacol (2001) 1.10
Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia. Lancet (1984) 1.10
Reduced folate carrier expression in acute lymphoblastic leukemia: a mechanism for ploidy but not lineage differences in methotrexate accumulation. Blood (1999) 1.09
ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy. Leukemia (2011) 1.08
Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1. Leukemia (2009) 1.07
Pharmacokinetics of vincristine in children and adolescents with acute lymphocytic leukemia. J Pediatr (1994) 1.07
Pharmacokinetics of subcutaneous recombinant human granulocyte colony-stimulating factor in children. Blood (1992) 1.05
Lead poisoning from ingestion of Chinese herbal medicine. Clin Toxicol (1977) 1.04
Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science (1995) 1.04
TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance. J Clin Oncol (1997) 1.04
Liver volume as a determinant of drug clearance in children and adolescents. Drug Metab Dispos (1995) 1.04
Lower prevalence of the debrisoquin oxidative poor metabolizer phenotype in American black versus white subjects. Clin Pharmacol Ther (1991) 1.03
A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity. Leukemia (2010) 1.03
Age-related differences in hepatic drug clearance in children: studies with lorazepam and antipyrine. Clin Pharmacol Ther (1991) 1.02
Effect of fenugreek, onion and garlic on blood glucose and histopathology of pancreas of alloxan-induced diabetic rats. Indian J Med Sci (2005) 1.01
Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype. Hum Mol Genet (1994) 1.01
Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia. Leukemia (1998) 1.01
Oral cancer chemotherapy: the promise and the pitfalls. Clin Cancer Res (1999) 1.01
Ligation of CD38 suppresses human B lymphopoiesis. J Exp Med (1995) 1.01
Etoposide achieves potentially cytotoxic concentrations in CSF of children with acute lymphoblastic leukemia. J Clin Oncol (1996) 1.00
Sex differences in prognosis for children with acute lymphoblastic leukemia. J Clin Oncol (1999) 1.00
Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target. Leukemia (2012) 1.00
Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia. Leukemia (1998) 1.00
Comprehensive characterization of mesenchymal stem cells from human placenta and fetal membrane and their response to osteoactivin stimulation. Stem Cells Int (2012) 0.99
Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans. J Pharmacol Exp Ther (1994) 0.99
Adjuvant chemotherapy for osteosarcoma of the extremity. Long-term results of two consecutive prospective protocol studies. Cancer (1990) 0.99
Therapeutic drug monitoring in cancer management. Clin Chem (1993) 0.99
Aspirin alters methotrexate disposition in rheumatoid arthritis patients. Arthritis Rheum (1991) 0.97